Therapeutic Potential of „Derived-Multiple Allogeneic Proteins Paracrine Signaling-D-Mapps” in the Treatment of Dry Eye Disease
暂无分享,去创建一个
N. Arsenijević | V. Volarevic | P. Karpecki | C. Harrell | Crissy Fellabaum | B. S. Markovic | Dragica Miloradovic | Dragana Miloradovic | Aleksandar Acović
[1] N. Arsenijević,et al. Exo-D-Mapps Attenuates Production of Inflammatory Cytokines and Promoted Generation of Immunosuppressive Phenotype in Peripheral Blood Mononuclear Cells , 2019, Serbian Journal of Experimental and Clinical Research.
[2] A. Arsenijević,et al. Therapeutic Potential of “Exosomes Derived Multiple Allogeneic Proteins Paracrine Signaling: Exosomes d-MAPPS” is Based on the Effects of Exosomes, Immunosuppressive and Trophic Factors , 2019, Serbian Journal of Experimental and Clinical Research.
[3] N. Arsenijević,et al. Galectin-3 Regulates Indoleamine-2,3-dioxygenase-Dependent Cross-Talk between Colon-Infiltrating Dendritic Cells and T Regulatory Cells and May Represent a Valuable Biomarker for Monitoring the Progression of Ulcerative Colitis , 2019, Cells.
[4] Jinsong Zhang,et al. Rebamipide ophthalmic solution modulates the ratio of T helper cell 17/regulatory T cells in dry eye disease mice , 2019, Molecular medicine reports.
[5] N. Zahr,et al. Sirolimus and mTOR Inhibitors: A Review of Side Effects and Specific Management in Solid Organ Transplantation , 2019, Drug Safety.
[6] M. Cifuentes,et al. Regenerative Therapies in Dry Eye Disease: From Growth Factors to Cell Therapy , 2017, International journal of molecular sciences.
[7] J. Schuman,et al. Treg‐recruiting microspheres prevent inflammation in a murine model of dry eye disease , 2017, Journal of controlled release : official journal of the Controlled Release Society.
[8] K. Tsubota,et al. TFOS DEWS II Definition and Classification Report. , 2017, The ocular surface.
[9] M. Milovanovic,et al. In vitro and in vivo anti-tumor effects of selected platinum(IV) and dinuclear platinum(II) complexes against lung cancer cells , 2017, JBIC Journal of Biological Inorganic Chemistry.
[10] R. Dana,et al. T Cell–Derived Granulocyte-Macrophage Colony-Stimulating Factor Contributes to Dry Eye Disease Pathogenesis by Promoting CD11b+ Myeloid Cell Maturation and Migration , 2017, Investigative ophthalmology & visual science.
[11] Mitchell A Jackson,et al. Dysfunctional tear syndrome: dry eye disease and associated tear film disorders – new strategies for diagnosis and treatment , 2017, Current opinion in ophthalmology.
[12] T. Gadek,et al. Development of lifitegrast: a novel T-cell inhibitor for the treatment of dry eye disease , 2016, Clinical ophthalmology.
[13] Kofi Fred Asiedu,et al. Ocular Surface Disease Index (OSDI) Versus the Standard Patient Evaluation of Eye Dryness (SPEED): A Study of a Nonclinical Sample , 2016, Cornea.
[14] L. Marshall,et al. Treatment of Dry Eye Disease. , 2016, The Consultant pharmacist : the journal of the American Society of Consultant Pharmacists.
[15] P. Asbell,et al. Clinical guidelines for management of dry eye associated with Sjögren disease. , 2015, The ocular surface.
[16] E. Messmer. The pathophysiology, diagnosis, and treatment of dry eye disease. , 2015, Deutsches Arzteblatt international.
[17] C. König,et al. Vergleich des OSDI- und SPEED-Fragbogens zur Evaluation des Sicca-Syndroms in der klinischen Praxis , 2014, Der Ophthalmologe.
[18] P. Asbell,et al. The Core Mechanism of Dry Eye Disease Is Inflammation , 2014, Eye & contact lens.
[19] S. Pflugfelder,et al. T helper cytokines in dry eye disease. , 2013, Experimental eye research.
[20] O. Lee,et al. Mesenchymal Stem Cells Tune the Development of Monocyte-Derived Dendritic Cells Toward a Myeloid-Derived Suppressive Phenotype through Growth-Regulated Oncogene Chemokines , 2013, The Journal of Immunology.
[21] R. Dana,et al. Dry eye disease: an immune-mediated ocular surface disorder. , 2012, Archives of ophthalmology.
[22] Hao Wang,et al. Regulatory T-Cell Generation and Kidney Allograft Tolerance Induced by Mesenchymal Stem Cells Associated With Indoleamine 2,3-Dioxygenase Expression , 2010, Transplantation.
[23] P. Puccetti,et al. Gut CD103+ dendritic cells express indoleamine 2,3-dioxygenase which influences T regulatory/T effector cell balance and oral tolerance induction , 2010, Gut.
[24] R. Dana,et al. Autoimmunity in Dry Eye Is Due to Resistance of Th17 to Treg Suppression1 , 2009, The Journal of Immunology.
[25] C. Kim,et al. Corneal epithelial cellular dysfunction from benzalkonium chloride (BAC) in vitro , 2004, Clinical & experimental ophthalmology.
[26] A. Arsenijević,et al. Molecular Mechanisms Responsible for Anti-inflammatory and Immunosuppressive Effects of Mesenchymal Stem Cell-Derived Factors. , 2019, Advances in experimental medicine and biology.
[27] A. Arsenijević,et al. Therapeutic Potential of Mesenchymal Stem Cell-Derived Exosomes in the Treatment of Eye Diseases. , 2018, Advances in experimental medicine and biology.
[28] S. Schrader,et al. [Comparison of the OSDI and SPEED questionnaires for the evaluation of dry eye disease in clinical routine]. , 2014, Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft.